Revealing tumor immunity after hematopoietic stem cell transplantation
CJ Wu, J Ritz - Clinical Cancer Research, 2009 - AACR
CJ Wu, J Ritz
Clinical Cancer Research, 2009•AACRAllogeneic hematopoietic stem cell transplantation is currently the most effective method for
inducing tumor immunity. However, the diversity of target antigens recognized by donor T
cells has not been established. New studies show that tumor-reactive T cells are directed
against diverse tumor-specific targets as well as minor histocompatibility antigens.
inducing tumor immunity. However, the diversity of target antigens recognized by donor T
cells has not been established. New studies show that tumor-reactive T cells are directed
against diverse tumor-specific targets as well as minor histocompatibility antigens.
Abstract
Allogeneic hematopoietic stem cell transplantation is currently the most effective method for inducing tumor immunity. However, the diversity of target antigens recognized by donor T cells has not been established. New studies show that tumor-reactive T cells are directed against diverse tumor-specific targets as well as minor histocompatibility antigens.
AACR